Trexquant Investment »

Nektar Therapeutics shares owned by Trexquant Investment

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Trexquant Investment from 13F filings

Historical chart of Trexquant Investment investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Trexquant Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Trexquant Investment

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.2M 92k 56.90

More positions owned by Trexquant Investment

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Costco Wholesale Corporation (COST)
Apple (AAPL)
Amazon (AMZN)
Tesla Motors (TSLA)
Accenture Plc Ireland Shs Class A (ACN)
Palantir Technologies Cl A (PLTR)
Caterpillar (CAT)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Honeywell International (HON)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Comcast Corp Cl A (CMCSA)

View all positions for Trexquant Investment

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
Renaissance Technologies

View all funds holding Nektar Therapeutics